Evidence map›Paper›PMID 34826058›Full record

ArticleSleep & breathing = Schlaf & Atmung2022

Multiple-access versus telemedicine home-based sleep apnea testing for obstructive sleep apnea (OSA) diagnosis: a cost-minimization study.

Marcello Di Pumpo, Mario Cesare Nurchis, Antonio Moffa, Lucrezia Giorgi, Lorenzo Sabatino, Peter Baptista, Lorenzo Sommella, Manuele Casale, Gianfranco Damiani

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Sleep & breathing = Schlaf & Atmung, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Marcello Di PumpoUniversità Cattolica del Sacro Cuore, Rome, Italy.
Mario Cesare NurchisUniversità Cattolica del Sacro Cuore, Rome, Italy. mariocesare.nurchis@unicatt.it.ORCID 0000-0002-9345-4292
Antonio MoffaIntegrated Therapies in Otolaryngology, Campus Bio-Medico University, Rome, Italy.
Lucrezia GiorgiIntegrated Therapies in Otolaryngology, Campus Bio-Medico University, Rome, Italy.
Lorenzo SabatinoIntegrated Therapies in Otolaryngology, Campus Bio-Medico University, Rome, Italy.
Peter BaptistaUnit of Otolaryngology, Clínica Universidad de Navarra, Pamplona, Spain.
Lorenzo SommellaHospital Management, Campus Bio-Medico University, Rome, Italy.
Manuele CasaleIntegrated Therapies in Otolaryngology, Campus Bio-Medico University, Rome, Italy.
Gianfranco DamianiUniversità Cattolica del Sacro Cuore, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of the present study was to compare two clinical pathways: the multiple-access outpatient pathway versus the telemedicine pathway.

methodsThe multiple-access outpatient pathway and the telemedicine pathway were both performed with WatchPAT and implemented in a real-life healthcare scenario, adopting a cost-minimization approach. A cost-minimization analysis was undertaken to assess the economic impact of the two alternatives. The cost analyses were performed in euros for the year 2021 adopting the patient, the hospital, and the societal perspectives. Given the chosen perspectives, direct medical costs, direct nonmedical costs, and indirect costs were considered. In addition, a univariate sensitivity analysis was conducted.

resultsFrom a hospital perspective, the telemedicine approach was estimated to cost €49 more than the multiple-access alternative. Considering the patient perspective, the telemedicine approach was estimated to cost €167 less than the multiple-access pathway. Considering the societal perspective, the telemedicine approach is estimated to cost €119 less than the multiple-access pathway.

conclusionThe adoption of telemedicine home sleep apnea testing could improve the efficiency of the healthcare processes if considering the direct and indirect costs incurred by patients and not only by healthcare providers.

Indexed as

Sleep Apnea, ObstructiveSleep Apnea SyndromesTelemedicineContinuous Positive Airway PressureHumansSleepCost-minimization analysisEfficiencyMultiple-accessObstructive sleep apneaTelemedicine

Identifiers

PMID34826058
PMCPMC8617356

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.